<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>off-the-shelf immunotherapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/off-the-shelf-immunotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 02 Dec 2025 17:28:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>off-the-shelf immunotherapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>CAR-NK Cell Therapy: Innovations to Clinical Breakthroughs</title>
		<link>https://bioengineer.org/car-nk-cell-therapy-innovations-to-clinical-breakthroughs/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 02 Dec 2025 17:28:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[CAR-NK therapy]]></category>
		<category><![CDATA[Genetic engineering]]></category>
		<category><![CDATA[immunotherapy breakthroughs]]></category>
		<category><![CDATA[off-the-shelf immunotherapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/car-nk-cell-therapy-innovations-to-clinical-breakthroughs/</guid>

					<description><![CDATA[In an era marked by rapid advancements in immunotherapy, a groundbreaking frontier has emerged—chimeric antigen receptor natural killer (CAR-NK) cell therapy. This innovative approach is revolutionizing the landscape of cancer treatment, harnessing the innate cytotoxic capabilities of natural killer cells combined with precise genetic engineering. Recent research detailed in an influential 2025 publication from the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">304401</post-id>	</item>
	</channel>
</rss>
